| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| APGE | Apogee Therapeutics, Inc. | Director | Jun 5, 2024 | |||
| HLXB | Helix Acquisition Corp. II | Director | Feb 8, 2024 | |||
| NAMS, NAMSW | NewAmsterdam Pharma Co N.V. | Director | Jul 17, 2024 | |||
| PCSC | Perceptive Capital Solutions Corp | Director | Jun 11, 2024 | |||
| RXDX | Prometheus Biosciences, Inc. | Chairman, President and CEO, Director | Jun 16, 2023 | |||
| SYRE | Spyre Therapeutics, Inc. | Director | Feb 1, 2024 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|